Greenspan M D, Bull H G, Yudkovitz J B, Hanf D P, Alberts A W
Department of Biochemical Regulation, Merck Research Laboratories, Rahway, NJ 07065-0900.
Biochem J. 1993 Feb 1;289 ( Pt 3)(Pt 3):889-95. doi: 10.1042/bj2890889.
The beta-lactones L-659,699 [(E,E)-11-[3-(hydroxymethyl)-4-oxo-2- oxetanyl]-3,5,7-trimethyl-2,4-undecadienoic acid) and its radioactive derivative 3H-L-668,411 (the 2,3-ditritiated methyl ester of L-659,699) inhibited a partially purified preparation of rat liver cytosolic 3-hydroxy-3-methylglutaryl-CoA (HMG-CoA) synthase with an IC50 of 0.1 microM. These compounds were also found to inhibit the incorporation of [14C]acetate into sterols in cultured Hep G2 cells with an IC50 of 3 microM. New kinetic evidence indicated that inhibition of the isolated enzyme was irreversible. In contrast, sterol biosynthesis in cultured Hep G2 cells was rapidly restored upon removal of the compound from the medium of inhibited cultures, suggesting reversibility of inhibition in the cells. Radioactivity was found to be associated with a single cytoplasmic protein by SDS/PAGE of the cytoplasm of Hep G2 cells after incubation of the cells with the inhibitor 3H-L-668,411. This protein was identified as cytoplasmic HMG-CoA synthase. Binding of the radioactive compound to the enzyme was decreased with time if the radioactive inhibitor was removed from the medium. Exposure of a gel containing the radioactive enzyme-inhibitor complex to neutral hydroxylamine also resulted in a loss of radioactivity from the gel. The purified rat liver enzyme reacted with the 3H-ligand to form a stable enzyme-inhibitor complex which could be isolated by h.p.l.c. Radioactivity was also subsequently lost from this complex when it was incubated with neutral hydroxylamine. Incorporation of [14C]acetate into cholesterol in mouse liver was inhibited in a reversible manner after oral administration of the beta-lactone inhibitor. These studies, as well as the kinetic evidence presented, suggest that the beta-lactone inhibitors acylate HMG-CoA synthase in a reaction which appears to be irreversible in vitro, but is easily reversed in cultured cells and in animals.
β-内酯L-659,699 [(E,E)-11-[3-(羟甲基)-4-氧代-2-氧杂环丁烷基]-3,5,7-三甲基-2,4-十一碳二烯酸]及其放射性衍生物3H-L-668,411(L-659,699的2,3-二氚代甲酯)抑制大鼠肝脏胞质3-羟基-3-甲基戊二酰辅酶A(HMG-CoA)合酶的部分纯化制剂,IC50为0.1微摩尔。还发现这些化合物抑制培养的Hep G2细胞中[14C]乙酸掺入甾醇,IC50为3微摩尔。新的动力学证据表明对分离酶的抑制是不可逆的。相反,从受抑制培养物的培养基中去除该化合物后,培养的Hep G2细胞中的甾醇生物合成迅速恢复,表明细胞中的抑制是可逆的。在用抑制剂3H-L-668,411孵育细胞后,通过Hep G2细胞胞质的SDS/PAGE发现放射性与一种单一的胞质蛋白相关。该蛋白被鉴定为胞质HMG-CoA合酶。如果从培养基中去除放射性抑制剂,放射性化合物与酶的结合会随时间减少。将含有放射性酶-抑制剂复合物的凝胶暴露于中性羟胺也会导致凝胶中放射性丧失。纯化的大鼠肝脏酶与3H-配体反应形成稳定的酶-抑制剂复合物,可通过高效液相色谱分离。当该复合物与中性羟胺孵育时,随后放射性也会从该复合物中丧失。口服β-内酯抑制剂后,小鼠肝脏中[14C]乙酸掺入胆固醇的过程受到可逆抑制。这些研究以及所提供的动力学证据表明,β-内酯抑制剂在体外反应中使HMG-CoA合酶酰化,该反应似乎是不可逆的,但在培养细胞和动物中很容易逆转。